.png){kind=icon}
.png){kind=icon}
Return
T-Cell Lymphomas, Version 2.2022
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2022.0015.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas. J Natl Compr Canc Netw 2022;20(3):285-308 doi: 10.6004/jnccn.2022.0015
Keywords:
POSITRON-EMISSION-TOMOGRAPHY
HIGH-DOSE CHEMOTHERAPY
PHASE-II TRIAL
NON-HODGKIN-LYMPHOMA
1ST COMPLETE REMISSION
LONG-TERM REMISSIONS
DETUDE DES LYMPHOMES
PROGNOSTIC-FACTORS
WORKING PARTY
ALLOGENEIC TRANSPLANTATION
Journal
J
IF:
16.4
Papers:
2.8K
Citations:
1.5W
Organization
View more organizations